PUBLICATIONS
NOP-Targeted Nonpeptide Ligands
Zaveri NT, Meyer ME
Handbook of Experimental Pharmacology. 2019 May 22
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S.
Science Signaling. 2019 March 26
Zaveri NT, Marquez PV, Meyer ME, Hamid A, Lufty K
Frontiers in Psychiatry. 2018 November 29
Neuronal nicotinic acetylcholine receptors mediate ∆9 -THC dependence: Mouse and human studies
Donvito G, Muldoon PP, Jackson KJ, Ahmad U, Zaveri NT, McIntosh JM, Chen X, Lichtman AH, Damaj MI
Addiction Biology. 2018 October 31
Ding H, Kiguchi N, Yasuda D, Daga PR, Polgar WE, Lu JJ, Czoty PW, Kishioka S, Zaveri NT, Ko MC
Science Translational Medicine. 2018 August 29
Arcuri L, Novello S, Frassineti M, Mercatelli D, Pisanò CA, Morella I, Fasano S, Journigan BV, Meyer ME, Polgar WE, Brambilla R, Zaveri NT, Morari M
British Journal of Pharmacology. 2018 March
A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl) piperidin-4-yl) -1H-indol-2-yl) methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice
Zaveri NT, Marquez PV, Meyer ME, Polgar WE, Hamid A, Lutfy K.
Alcoholism: Clinical and Experimental Research. 2018 February
Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs
Cippitelli A, Brunori G, Schoch J, Armishaw CJ, Wu J, Zaveri NT, Giulianotti MA, Welmaker GS, Toll L
Psychopharmacology (Berl). 2018 June
Journigan VB, Polgar WE, Tuan EW, Lu J, Daga PR, Zaveri NT
Scientific Reports. 2017 October 16
Ferrari F, Malfacini D, Journigan BV, Bird MF, Trapella C, Guerrini R, Lambert DG, Calo' G, Zaveri NT
Pharmacology Research and Perspectives. 2017 August
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation
Rekik K, Faria Da Silva R, Colom M, Pacifico S, Zaveri NT, Calo' G, Rampon C, Frances B, Mouledous L
Neuropharmacology. 2017 October
Yuan M, Malagon AM, Yasuda D, Belluzzi JD, Leslie FM, Zaveri NT
Behavioural Brain Research. 2017 August 30
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Kallupi M, Shen Q, de Guglielmo G, Yasuda D, Journigan VB, Zaveri NT, Ciccocioppo R
Addiction Biology. 2018 March
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations
Ferrari F, Cerlesi MC, Malfacini D, Asth L, Gavioli EC, Journigan BV, Kamakolanu UG, Meyer ME, Yasuda D, Polgar WE, Rizzi A, Guerrini R, Ruzza C, Zaveri NT, Calo G
European Journal of Pharmacology. 2016 December 15
Cippitelli A, Schoch J, Debevec G, Brunori G, Zaveri NT, Toll L
Scientific Reports. 2016 May 20
Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT
Pharmacological Reviews. 2016 April
Zaveri NT
Journal of Medicinal Chemistry. 2016 August 11
Asth L, Ruzza C, Malfacini D, Medeiros I, Guerrini R, Zaveri NT, Gavioli EC, Calo' G
Neuropharmacology. 2016 June